Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Second-cycle DCVAC/PCa after prostatectomy in localized prostate cancer
2013-003809-26Phase 2Completed
- Sponsor
- SOTIO Biotech
- Start
- Oct 2013
- Modality
- Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of DCvac in prostate cancer (PCa), sponsored by SOTIO Biotech. Started Oct 2013; status: completed.
02
Drugs
DCvac
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2013-003809-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003809-26.